1. Editor's page

   EditorialNotes Pages: i - i

2. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer

   • Hyman B. Muss
   • M. Robert Cooper
   • Charles L. Spurr

   Report Pages: 77 - 84

3. Prognostic value of total cathepsin D in breast tumors

   • Moïse Namer
   • Alain Ramaioli
   • Françoise Lapalus

   Report Pages: 85 - 93

4. Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease

   • T. Maudelonde
   • P. Lavaud
   • H. Rochefort

   Report Pages: 95 - 102

5. 65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness

   • Suzanne Jozan
   • Anne-Marie Julia
   • Jean Frédéric David

   Report Pages: 103 - 109

6. Incidence of an estrogen receptor polymorphism in breast cancer patients

   • Rita K. Schmutzler
   • Mercedes Sanchez
   • Beth Schachter

   Report Pages: 111 - 117

7. Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer

   • A. J. Vangsted
   • E. V. Andersen
   • J. Zeuthen

   Report Pages: 119 - 128

8. Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient

   • Elisabetta Campora
   • Cristina Oliva
   • Riccardo Rosso

   Brief Communication Pages: 129 - 132

9. Thursday, December 5, 1991 4th Annual San Antonio Flow Cytometry Forum

   Events Pages: 135 - 156

10. Abstracts

    Abstract Pages: 157 - 216